ロード中...
Gaseous nitric oxide reduces influenza infectivity in vitro
Gaseous nitric oxide (gNO) is an approved vasodilator drug for inhalation up to a maximum dose of 80 ppm. While gNO has been shown, in vitro, to be an effective antibacterial agent (at 160 ppm), NO-donor compounds have been shown to inhibit a variety of viruses at varying stages of replication. This...
保存先:
| 出版年: | Nitric Oxide |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Inc.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7110511/ https://ncbi.nlm.nih.gov/pubmed/23562771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.niox.2013.03.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|